HealthStream, Inc. (HSTM) fair value analysis

Nasdaq · Updated 2026-09-07

HealthStream, Inc. is a healthcare company that provides learning and training solutions, workforce management services, and other software platforms designed for healthcare organizations. The company operates in the United States and serves hospitals, health systems, and other healthcare providers.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, HSTM is trading at more than a 25% discount to estimated fair value.

HSTM currently ranks #26 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $28.33
Sector: Healthcare
12-month range: $20.37–$28.33

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Momentum grade: B
Leverage: Low
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range

What our data shows for HSTM

Our model validated 17 trailing price-to-earnings windows for HSTM, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $20.37–$28.33.
The 14-day relative strength index sits at a neutral 57.
3 of the last 12 weekly snapshots showed positive price momentum.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for HSTM
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent HSTM news

TickrTrends' derived news-sentiment signal for HSTM is currently mixed, computed from recent coverage.

HealthStream, Inc. (HSTM) Q2 2026 Earnings Call Transcript (seekingalpha.com, 2026-08-04)
TickrTrends take: HealthStream operates in the Healthcare sector where operational efficiency and revenue growth directly influence valuation multiples. According to TickrTrends' current assessment, HSTM is trading at levels below its derived valuation benchmark, which suggests the market may not be fully pricing in the company's earnings trajectory or sector dynamics. Investors monitoring the valuation context should examine whether Q2 2026 results and forward guidance support the undervalued designation or signal shifts in the company's competitive positioning within healthcare services and software.
HealthStream Q2 Earnings Call Highlights (finance.yahoo.com, 2026-08-04)
TickrTrends take: HealthStream operates in the Healthcare sector and is currently assessed by TickrTrends as undervalued based on its derived valuation metrics. A valuation-focused reader monitoring HSTM should pay particular attention to whether the company's Q2 earnings call reveals trends in revenue growth, margin expansion, or cash flow generation that might justify or challenge the undervalued designation. Given the company's position in healthcare, operational metrics related to customer retention, subscription renewals, and software implementation progress would be especially relevant to tracking whether the current valuation reflects the company's true earning power.

What people are saying

Follow the HSTM conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is HSTM stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), HSTM is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is HSTM's TickrTrends verdict?

HSTM's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does HSTM compare to other Healthcare stocks?

HSTM ranks #26 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is HSTM overbought or oversold?

HSTM's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

HSTM vs AVAH · HSTM vs GEHC · HSTM vs HQY · HSTM vs IDXX · HSTM vs INDV